骨髓微环境调控MLL::AF9白血病干细胞的氧化还原与能量平衡
该研究在MLL::AF9诱导的急性髓系白血病(AML)模型中揭示,Prx1+间充质细胞而非成熟骨系细胞产生的CXCL12是维持白血病干细胞(LSC)的关键因素。Prx1+细胞通过调节LSC的能量代谢和氧化还原平衡促进其存活;敲除Cxcl12导致LSC内活性氧积累和DNA损伤,移植实验中白血病延续能力受损,抗氧化治疗可减轻该缺陷。数据提示该现象在人类患者中可能保守。
要点
- Prx1+间充质细胞产生的CXCL12维持MLL::AF9 AML模型骨髓中的LSC。
- 敲除Cxcl12导致LSC活性氧积累和DNA损伤,移植中白血病延续能力受损。
- 抗氧化治疗可减轻Cxcl12敲除所致LSC缺陷,数据提示该现象在人类患者中可能保守。
核心结论
- Prx1+间充质细胞是微环境与AML代谢交织的组成部分,CXCL12/CXCR4可作为清除AML实质LSC的靶点。
研究设计与样本
- 研究在MLL::AF9诱导的AML模型中进行,并结合移植实验评估LSC功能。
主要发现
- Prx1+间充质细胞而非成熟骨系细胞产生的CXCL12为维持骨髓中LSC提供必要信号。
- Prx1+细胞通过调节LSC能量代谢和氧化还原平衡促进LSC存活。
- 敲除Cxcl12导致LSC中活性氧积累和DNA损伤,移植实验中LSC延续白血病能力受损。
- 抗氧化治疗可减轻Cxcl12敲除所致的LSC缺陷。
- 数据提示该现象在人类患者中可能保守。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Eradicating leukemia requires a deep understanding of the interaction between leukemic cells and their protective microenvironment. The CXCL12/CXCR4 axis has been postulated as a critical pathway dictating leukemia stem cell (LSC) chemoresistance in AML due to its role in controlling cellular egress from the marrow. Nevertheless, the cellular source of CXCL12 in the acute myeloid leukemia (AML) microenvironment and the mechanism by which CXCL12 exerts its protective role in vivo remain unresolved. Here, we show that CXCL12 produced by Prx1+ mesenchymal cells but not by mature osteolineage cells provide the necessary cues for the maintenance of LSCs in the marrow of an MLL::AF9-induced AML model. Prx1+ cells promote survival of LSCs by modulating energy metabolism and the REDOX balance in LSCs. Deletion of Cxcl12 leads to the accumulation of reactive oxygen species and DNA damage in LSCs, impairing their ability to perpetuate leukemia in transplantation experiments, a defect that can be attenuated by antioxidant therapy. Importantly, our data suggest that this phenomenon appears to be conserved in human patients. Hence, we have identified Prx1+ mesenchymal cells as an integral part of the complex niche-AML metabolic intertwining, pointing towards CXCL12/CXCR4 as a target to eradicate parenchymal LSCs in AML.
引用
- Viñado AC, Calvo IA, Cenzano I, et al. The bone marrow niche regulates redox and energy balance in MLL::AF9 leukemia stem cells. Leukemia. 2022. PMID: 35618797. doi:10.1038/s41375-022-01601-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。